AORT - Artivion, Inc.
NEXT EARNINGS:
May 4, 2026
EPS Est: $0.06
|
Rev Est: $115.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$50.50
DETAILS
HIGH:
$51.00
LOW:
$50.00
MEDIAN:
$50.50
CONSENSUS:
$50.50
UPSIDE:
42.86%
Market Cap:
1.69B
Volume:
565,778
Avg Volume:
375,551
52 Week Range:
21.97-48.25
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.58
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
1,600
IPO Date:
1993-02-12
EPS (TTM):
0.22
P/E Ratio:
211.68
Revenue (TTM):
441.33M
Total Assets:
884.80M
Total Debt:
292.04M
Cash & Equiv:
64.91M
Rev Growth (5Y):
11.8%
EPS Growth (5Y):
-4.4%
FCF Growth (5Y):
7.3%
ROCE:
3.4%
Debt/Equity:
0.65
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-12 | $0.17 | $0.14 | +21.4% | $116.0M | $112.8M | +2.8% |
| 2025-11-06 | $0.16 | $0.14 | +14.3% | $113.4M | $116.4M | -2.6% |
| 2025-08-07 | $0.24 | $0.11 | +118.2% | $113.0M | $107.4M | +5.1% |
| 2025-05-05 | $0.06 | $0.12 | -50.0% | $99.0M | $108.5M | -8.8% |
| 2025-02-24 | $-0.39 | $0.12 | -425.0% | $97.3M | $100.8M | -3.5% |
| 2024-11-07 | $0.12 | $0.10 | +20.6% | $95.8M | $101.2M | -5.3% |
| 2024-08-08 | $0.07 | $-0.49 | +114.3% | $98.0M | $97.7M | +0.4% |
| 2024-05-06 | $0.06 | $0.02 | +170.3% | $97.4M | $92.0M | +5.9% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 441.33M | 388.54M | 354.00M | 313.79M | 298.84M | 253.23M | 276.22M | 262.84M | 189.70M | 180.38M | 145.90M | 144.64M |
| Net Income | 9.77M | (13.36M) | (30.69M) | (19.19M) | (14.83M) | (16.68M) | 1.72M | (3.81M) | 3.70M | 10.78M | 4.00M | 7.32M |
| EPS | 0.22 | -0.32 | -0.75 | -0.48 | -0.38 | -0.44 | 0.05 | -0.11 | 0.11 | 0.33 | 0.14 | 0.26 |
| Total Assets | 884.80M | 789.10M | 792.40M | 762.80M | 793.05M | 789.40M | 605.65M | 571.09M | 591.67M | 316.14M | 181.18M | 176.16M |
| Total Debt | 292.04M | 362.26M | 358.34M | 356.83M | 362.04M | 317.37M | 245.15M | 223.55M | 226.39M | 71.57M | 0 | 0 |
| Cash & Equivalents | 64.91M | 53.46M | 58.94M | 39.35M | 55.01M | 61.41M | 33.77M | 41.49M | 40.75M | 57.34M | 43.42M | 33.38M |
| Operating Cash Flow | 38.13M | 22.24M | 18.82M | (5.15M) | (2.58M) | 12.37M | 15.83M | 9.88M | 10.80M | 19.72M | 11.44M | 8.12M |
| Free Cash Flow | (911,000) | 11.05M | 11.39M | (15.87M) | (15.68M) | 5.04M | 7.75M | 4.09M | 3.76M | 12.29M | 7.34M | 2.80M |
| FCF per Share | -0.02 | 0.27 | 0.28 | -0.40 | -0.40 | 0.13 | 0.21 | 0.12 | 0.11 | 0.39 | 0.26 | 0.10 |
| Book Value | 448.23M | 276.20M | 281.78M | 284.33M | 300.73M | 328.71M | 285.70M | 275.07M | 279.04M | 208.98M | 155.25M | 148.69M |
| Cash & ST Investments | 64.91M | 53.46M | 58.94M | 39.35M | 55.01M | 61.41M | 33.77M | 41.49M | 40.75M | 57.34M | 43.42M | 33.38M |
| ROC Equity | 0.02 | -0.05 | -0.11 | -0.07 | -0.05 | -0.05 | 0.01 | -0.01 | 0.01 | 0.05 | 0.03 | 0.05 |